1 TECHNICLONE INTERNATIONAL CORPORATION A CALIFORNIA CORPORATION REGULATION S SECURITIES SUBSCRIPTION AGREEMENT THE PREFERRED STOCK BEING SUBSCRIBED FOR HEREIN AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THE PREFERRED STOCK (COLLECTIVELY THE...Techniclone International Corp • January 24th, 1996 • In vitro & in vivo diagnostic substances • California
SECOND AMENDMENT TO REGULATION D COMMON STOCK EQUITY LINE SUBSCRIPTION AGREEMENTSubscription Agreement • September 18th, 1998 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances
R E C I T A L S - - - - - - - -Option Agreement • December 15th, 1998 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.84 FORM OF ZLP REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of August 9, 2002, by and among Peregrine Pharmaceuticals, Inc., a Delaware...Registration Rights Agreement • September 4th, 2002 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
and SCHERING AGLicense Agreement • May 18th, 2000 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • New York
R E C I T A L S: - - - - - - - -Security Agreement • July 28th, 1999 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • California
EXHIBIT 4.18Non-Qualified Stock Option Agreement • June 23rd, 2003 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
WARRANT TO PURCHASE COMMON STOCK OF TECHNICLONE CORPORATIONTechniclone Corp/De/ • June 29th, 1998 • In vitro & in vivo diagnostic substances
EXHIBIT 10.64 TECHNICLONE CORPORATION REGULATION D SUBSCRIPTION AGREEMENT THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE OR OTHER SECURITIES AUTHORITIES. THEY MAY NOT BE SOLD OR...Subscription Agreement • May 18th, 2000 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances
1 EXHIBIT 4.2 FORM OF STOCK OPTION AGREEMENT PERTAINING TO THE 1996 PLAN INCENTIVE STOCK OPTION AGREEMENT (GRANTED UNDER THE 1996 STOCK INCENTIVE PLAN) This Incentive Stock Option Agreement (the "Agreement") is entered into as of...Incentive Stock Option Agreement • December 9th, 1996 • Techniclone International Corp • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.79 FORM OF REGISTRATION RIGHTS AGREEMENT UNDER SECURITIES PURCHASE AGREEMENT REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of August 9, 2002, by and among Peregrine...Registration Rights Agreement • September 4th, 2002 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE AGREEMENT UP TO 5,000,000 SHARES OF COMMON STOCKCommon Stock Purchase Agreement • March 14th, 2005 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
CREDIT AGREEMENT Dated as of March 14, 2023 among AVID BIOSERVICES, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer, and THE LENDERS PARTY...Credit Agreement • March 15th, 2023 • Avid Bioservices, Inc. • Pharmaceutical preparations • New York
ARTICLE I. DEFINITIONSSecurities Purchase Agreement • September 4th, 2002 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
1 MERGER AGREEMENT THIS MERGER AGREEMENT ("Merger Agreement") is made and entered into as of the 10th day of June 1994 by and between TECHNICLONE INTERNATIONAL CORPORATION, a California corporation ("Company"), and CANCER BIOLOGICS INCORPORATED, a...Merger Agreement • January 24th, 1996 • Techniclone International Corp • In vitro & in vivo diagnostic substances
AGREEMENTDistribution Agreement • March 7th, 1996 • Techniclone International Corp • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.50 PLEDGE AND SECURITY AGREEMENT THIS PLEDGE AND SECURITY AGREEMENT ("Agreement") dated as of December 24, 1998 is between C. FREDERICK WEHBA II, CHAD W. WEHBA, CHRISTIAN F. WEHBA, CYLE F. WEHBA 1998 TRUST, GFW TRUST, AND TPF TRUST III...Pledge and Security Agreement • March 12th, 1999 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • California
ARTICLE I. DEFINITIONSSecurities Purchase Agreement • September 4th, 2002 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
AVID BIOSERVICES, INC., as Issuer AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of March 12, 2024Indenture • March 14th, 2024 • Avid Bioservices, Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of March 12, 2024 between Avid Bioservices, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. Bank TRUST COMPANY, National Association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
LIMITED LIABILITY COMPANY AGREEMENTLimited Liability Company Agreement • July 3rd, 2000 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • Delaware
PATENT LICENSE AGREEMENT BETWEEN UNIVERSITY OF TEXAS SYSTEM AND TECHNICLONE CORPORATION THIS PATENT LICENSE AGREEMENT ("LICENSE AGREEMENT") is made by and between the BOARD OF REGENTS (BOARD) OF THE UNIVERSITY OF TEXAS SYSTEM (SYSTEM), an agency of...License Agreement • September 10th, 1999 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • Texas
EXHIBIT 10.65 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT ("Agreement") is entered into as of January 6th, 2000, by and among Techniclone Corporation. a corporation duly incorporated and existing under the laws of the State of...Registration Rights Agreement • March 16th, 2000 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • Delaware
AGREEMENTAgreement • February 8th, 1996 • Techniclone International Corp • In vitro & in vivo diagnostic substances
1 EXHIBIT 2.1Stock Exchange Agreement • May 12th, 1997 • Techniclone International Corp • In vitro & in vivo diagnostic substances
REGULATION D COMMON STOCK EQUITY LINE SUBSCRIPTION AGREEMENTSubscription Agreement • April 30th, 1999 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • Delaware
RECITALSWaiver Agreement • July 3rd, 2000 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances
RECITALS:Placement Agent Agreement • September 18th, 1998 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • Delaware
WARRANT TO PURCHASE COMMON STOCK OF TECHNICLONE CORPORATIONTechniclone Corp/De/ • March 16th, 2000 • In vitro & in vivo diagnostic substances
CONFIDENTIALPeregrine Pharmaceuticals Inc • June 28th, 2007 • In vitro & in vivo diagnostic substances • New York
This letter (the “Agreement”) constitutes the agreement between Rodman & Renshaw, LLC (“R&R” or the “Placement Agent”) and Peregrine Pharmaceuticals, Inc. (the “Company”), that R&R shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered securities (the “Securities”) of the Company, including shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and supersedes all prior oral and written agreements, communications, and understandings. The terms of such Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that R&R would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents ex
AMENDED AND RESTATED RIGHTS AGREEMENT by and between PEREGRINE PHARMACEUTICALS, INC. and BROADRIDGE CORPORATE ISSUER SOLUTIONS, INC. as Rights Agent Amended and Restated as of March 16, 2016Rights Agreement • March 17th, 2016 • Peregrine Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amended and Restated Rights Agreement, entered into as of March 16, 2016 (this “Agreement”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent (the “Rights Agent”, which shall include any successor Rights Agent hereunder), amends and restates that certain Rights Agreement, dated as of March 16, 2006 (the “Original Agreement”), between the Company and the Rights Agent.
EXHIBIT 10.47 REAL ESTATE PURCHASE AGREEMENT ------------------------------Real Estate Purchase Agreement • March 12th, 1999 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances
RECITALS:Registration Rights Agreement • June 29th, 1998 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.71Agreement • September 14th, 2000 • Techniclone Corp/De/ • In vitro & in vivo diagnostic substances
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2007 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 28, 2007, between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
1 TECHNICLONE INTERNATIONAL: REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT ("Agreement") is entered into as of December , 1995, by and among Techniclone International Corporation, a California corporation ("Company") Swartz...: Registration Rights Agreement • January 24th, 1996 • Techniclone International Corp • In vitro & in vivo diagnostic substances • California
